Grifols (NASDAQ:GRFS) holder Mason Capital said it's against a potential sale of the Spanish drugmaker to BrookfieldAssetManagement (BAM). Mason Capital, which has a 2.1% stake in Grifols ...
Some results have been hidden because they may be inaccessible to you